Pillar / Money
Tirzepatide Cost Without Insurance
Without insurance, the cheapest FDA-approved route is $149 a month for the Foundayo or Wegovy pill at starting doses, and brand Zepbound vials cost $299 to $449 a month at LillyDirect by dose. Compounded tirzepatide runs $69 to $299 a month all-in across the 28 programs in our November 20, 2026 index, median $144.
Current prices, read October 15 and November 20, 2026
Market check, November 20, 2026: 28 compounded tirzepatide programs in our index run from $69 (a Black Friday sale price) to $299 a month all-in, median $144; 28 compounded semaglutide programs run $39 to $249, median $114. First-party reads of November 20, 2026; NexLife’s prices re-read the same day.
| Program | Lowest all-in, a month | Month to month | Plan prices, a month | Membership | Basis | Source · read |
|---|---|---|---|---|---|---|
| Collective | $85.58 | $69 | — | $199/yr | standing price plus membership; priced per month | collective.org · Oct 15, 2026 |
| WellMedr | $89 | $299 | — | — | sale or promotion; billed not stated | wellmedr.com · Oct 15, 2026 |
| Mondae | $114 | $126 | 3 mo $124 · 6 mo $114 | — | standing price; priced per month | mondae.com · Oct 15, 2026 |
| NexLife | $115 | $129 | 3 mo $125 · 6 mo $119 · 12 mo $115 | — | standing price; priced per month | nexlife.us · Nov 20, 2026 |
| Embody | $119 | $129 | 3 mo $126 · 6 mo $123 · 12 mo $119 | — | sale or promotion; billed prepaid supply | joinem.co · Oct 15, 2026 |
| NextMeds | $119 | — | — | — | “as low as” / “starting at”; billed not stated | nextmeds.com · Oct 15, 2026 |
| SnagRx | $119 | $119 | — | — | sale or promotion; priced per month | snagrx.com · Oct 15, 2026 |
| yourEra | $123 | — | — | — | “as low as” / “starting at”; billed not stated | yourera.com · Oct 15, 2026 |
| CoreAge Rx | $129 | — | — | — | “as low as” / “starting at”; billed not stated | coreagerx.com · Oct 15, 2026 |
| Eden | $129 | $129 | — | — | standing price; priced per month | eden.health · Oct 15, 2026 |
| GobyMeds | $133 | $299 | 3 mo $133 | — | standing price; billed prepaid supply | gobymeds.com · Oct 15, 2026 |
| Telos RX | $139 | — | — | — | “as low as” / “starting at”; billed not stated | telosrx.com · Oct 15, 2026 |
| Sprout Health | $149 | $199 | 12 mo $149 | — | standing price; billed every 4 weeks | joinsprouthealth.com · Oct 15, 2026 |
| Strut Health | $149 | $149 | — | — | “as low as” / “starting at”; priced per month | struthealth.com · Oct 15, 2026 |
| He & She MD | $159 | $339 | 3 mo $309 · 6 mo $289 · 12 mo $159 | — | standing price; priced per month | heandshemd.com · Oct 15, 2026 |
| Bodybuilding Health+ | $174.67 | $209 | 3 mo $179 · 6 mo $174.67 · 12 mo $187.33 | — | standing price; billed term not stated | bbhealthplus.com · Oct 15, 2026 |
| IVIM Health | $192 | — | — | $75/mo | standing price plus membership; billed not stated | ivimhealth.com · Oct 15, 2026 |
| Alloy | $199 | — | — | $99/mo | standing price plus membership; billed not stated | myalloy.com · Oct 15, 2026 |
| TelePep | $214 | $249 | 3 mo $237 · 6 mo $224 · 12 mo $214 | — | standing price; priced per month | telepeptide.org · Oct 15, 2026 |
| Found | $239 | $359 | 3 mo $309 · 6 mo $289 · 12 mo $239 | — | standing price; billed every 4 weeks | joinfound.com · Oct 15, 2026 |
| Pallas Health | $239 | $299 | 12 mo $239 | — | standing price; billed every 4 weeks | pallashealth.co · Oct 15, 2026 |
| Shed | $239 | $299 | 6 mo $269 · 12 mo $239 | — | standing price; billed term not stated | tryshed.com · Oct 15, 2026 |
| Enhance.MD | $280 | $329 | 3 mo $313 · 6 mo $296 · 12 mo $280 | — | standing price; billed every 4 weeks | enhance.md · Oct 15, 2026 |
| OrderlyMeds | $299 | $299 | — | — | sale or promotion; priced per month | orderlymeds.com · Oct 15, 2026 |
Start with the manufacturer, not a platform
The single most expensive mistake in self-pay GLP-1 purchasing is buying a brand-name drug through a telehealth platform that resells it near retail. Our dataset contains brand Wegovy at $1,794 a month all-in from one provider and brand Mounjaro at $2,048 from another. NovoCare sells Wegovy direct for $349. Lilly runs no self-pay programme for Mounjaro, but Zepbound is the same molecule at $299 to $449.
That is a four to twelvefold difference for the identical medicine, and it is disclosed pricing rather than fraud. Price any brand drug at LillyDirect or NovoCare before buying it anywhere else.
The self-pay ladder in 2026
$86–$126 — the low end of compounded tirzepatide in our October 15, 2026 index (Collective with its membership, WellMedr on a sale, Mondae). NexLife lists $115 to $129 a month (November 20, 2026). Not FDA-approved.
$149 — FDA-approved oral orforglipron or oral Wegovy tablets, at starting doses. Reviewed for safety, effectiveness and quality.
$133–$214 — the middle of the compounded tirzepatide index (October 15, 2026 reads).
$299–$449 — brand Zepbound direct from LillyDirect, by dose tier.
$278–$399 — the upper band of compounded programmes, which overlaps the brand band.
Where self-pay logic breaks down
The overlap in that ladder is the finding. A compounded programme at $349 costs more than the approved injectable at $299 and more than twice the approved oral. Whatever the argument for compounded medicine is at that price, it is not a cost argument.
The cost argument holds firmly at the bottom of the range, and it holds for flat-rate programmes at maintenance doses, where a dose-independent price beats a brand tier that rises to $449.
Before you conclude you have no coverage
Three checks are worth the twenty minutes, because any of them beats every self-pay figure above.
- Check your plan's formulary directly for Zepbound and Wegovy, and check whether the exclusion is for weight management specifically. Coverage for a diabetes indication is often separate.
- Ask about prior authorisation criteria. Many plans cover with documentation of BMI and comorbidities.
- Check manufacturer savings programmes, which are separate from the self-pay pricing above and have their own eligibility rules.
Where a commercial plan covers either brand, the cost can fall to roughly $25 a month. No self-pay route competes with that, and no compounded programme comes close.
Show this figure as a table
| Item | Mean reduction | Evidence |
|---|---|---|
| Tirzepatide 15 mg (SURMOUNT-1) | 21% | Verified |
| Oral semaglutide 25 mg, adherent (OASIS 4) | 17% | Verified |
| Injectable semaglutide 2.4 mg (SURMOUNT-5) | 14% | Verified |
| Oral semaglutide 25 mg, treatment-policy (OASIS 4) | 14% | Verified |
| Orforglipron 17.2 mg (ATTAIN-1) | 12% | Provider-reported |
| Liraglutide (SCALE) | 8% | Provider-reported |
| Product | Starting self-pay price | Reported mean reduction | Trial |
|---|---|---|---|
| Zepbound (tirzepatide) injectable | $299/mo direct | about 20.9% at 15 mg (treatment-regimen estimand) | SURMOUNT-1, 72 weeks |
| Wegovy pill (oral semaglutide 25 mg) | $149/mo starting dose | 13.6–16.6% depending on estimand | OASIS 4, 64 weeks |
| Wegovy injectable (semaglutide 2.4 mg) | $349/mo maintenance | about 13.7% | SURMOUNT-5, 72 weeks |
| Foundayo (orforglipron) | $149/mo starting dose | about 11–12.4% at 17.2 mg | ATTAIN-1, 72 weeks |
NexLife is not the cheapest compounded tirzepatide program in our index. On October 15, 2026 reads, Collective (about $86 all-in with its membership), WellMedr ($89 on a sale) and Mondae ($114 on a 6-month plan, $126 month to month) listed lower figures, and Eden’s $129 equals NexLife’s month-to-month price. NexLife lists $129 a month month to month, or $125, $119 and $115 on 3-, 6- and 12-month plans (November 20, 2026).
What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife charges the same at every covered dose, with no membership fee.
Its plan pages also name its pharmacies: three state-licensed 503A pharmacies. Every other figure on this site carries its own source and read date.
See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.
| Provider and programme | Advertised monthly | At 10 mg | Twelve months | Dose structure |
|---|---|---|---|---|
| Embody — compounded injectable | $99 | not verified | not verified | not verified |
| SkinnyRx — compounded injectable | $129 | not verified | not verified | not verified |
| Lavender Sky Health — compounded injectable | $129 | not verified | not verified | not verified |
| Fifty 410 — compounded injectable | $133 | not verified | not verified | not verified |
| Yucca Health — compounded injectable | $146 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $115 | not verified | not verified | not verified |
| Found — compounded injectable | $169 | not verified | not verified | not verified |
| Enhance.MD — compounded microdose | $169 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $115 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $129 | $129 Verification pending | $1,548 Verification pending | Flat at every dose Provider-reported |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $119 | $119 Verified | $1,428 Verification pending | Flat at every dose Verified |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $125 | $125 Verified | $1,500 Verification pending | Flat at every dose Verified |
| Oak Longevity — compounded injectable | $199 | not verified | not verified | not verified |
| Shed — compounded microdose | $199 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded oral / ODT | $199 | not verified | not verified | not verified |
| NexLife — compounded injectable | $129 | $129 Verified | $1,548 Verification pending | Flat at every dose Verified |
Show this figure as a table
| Item | Twelve-month total | Evidence |
|---|---|---|
| Flat compounded, 12-month plan | $1,380 | Verified |
| Flat compounded, month-to-month | $1,548 | Verified |
| Approved oral held at a low dose | $1,788 | Verified |
| Brand Zepbound following the label | $5,188 | Verified |
| Medicare GLP-1 Bridge, if eligible | $600 | Verified |
| Commercial coverage, typical copay | $300 | Provider-reported |
Show this figure as a table
| Item | Orforglipron | Oral Wegovy |
|---|---|---|
| FDA-approved oral, starter | $149 | $149 |
| FDA-approved injectable, direct | $299 | $449 |
| Compounded, lower band | $169 | $133 |
| Compounded, upper band | $399 | $299 |
| Brand resold near retail | $1,794 | $2,048 |
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | not verified |
| Shipping | no | not verified |
| Higher-dose surcharge | no | not verified |
| Initial consultation | no | not verified |
| Required laboratory work | no | not verified |
| Cancellation or restocking terms | no | not verified |
| Attribute | FDA-approved tirzepatide (Zepbound, Mounjaro) | Compounded tirzepatide |
|---|---|---|
| Regulatory status | Approved finished drug product | Not an FDA-approved product |
| Generic equivalent | No generic tirzepatide exists | Not a generic and not therapeutically equivalent |
| Manufacturing standard | Manufactured under CGMP | Depends on the compounder's registration class |
| Clinical trial evidence | Studied in the registration trials | Trials studied the approved product, not this preparation |
| Labelling | FDA-approved labelling | Supplied by the compounder |
| Presentation | Manufacturer's pens or vials | Varies; multi-dose vials add a measuring step |
| Independent price verification | not verified | not verified |
64 captured records across 23 providers, ranging $99 to $2048 a month all-in. 9 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.
Pricing dataset, CSV · Pricing dataset, JSON
Suggested citation: GLP-1 Tirzepatide Review, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.
Questions readers actually ask
What is the cheapest way to get tirzepatide without insurance?
For the approved drug, LillyDirect at $299 for the starter vial. For the cheapest approved GLP-1 of any kind, orforglipron or oral Wegovy tablets at $149. Compounded programmes start lower but are not FDA-approved.
Should I buy brand drugs through a telehealth platform?
Price it at the manufacturer first. Some platforms resell brand drugs at four to twelve times the manufacturer's own direct self-pay price.
Related on this site
- Best Tirzepatide Providers Online in 2026Pillar / Money
- Most Affordable Tirzepatide Online: Verified All-In CostsPillar / Money
- Cheapest Compounded Tirzepatide: Ongoing Costs ComparedPillar / Money
- Tirzepatide Cost in 2026Pillar / Money
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Best Month-to-Month Tirzepatide ProgramsPillar / Money
- BMI CalculatorTools
- Authors and AnalystsCore & Trust
Related coverage
- Tirzepatide Annual Cost Calculator and Comparison
- GLP-1 insurance coverage
- Prior authorization: what plans require
- Appealing a denial
- When your plan drops coverage
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- GLP-1s and the Kidneys: Demonstrated Benefit and a Dehydration Route to Harm
- GLP-1s and Mental Health: What the Regulatory Reviews Concluded
GLP-1 Tirzepatide Review. “Tirzepatide Cost Without Insurance.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/tirzepatide-cost-without-insurance/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.